FGF23 and hyperphosphatemia: Similar to FGF23- or αKlotho-deficient mice, patients with chronic kidney disease (CKD), which are typically characterized by high FGF23 levels and low αKlotho expression, suffer from the sequelae of hyperphosphatemia which drastically increase their cardiovascular mortality [16].